Madrigal Pharmaceuticals Inc (MDGL)
215.99
+5.91
(+2.81%)
USD |
NASDAQ |
May 02, 16:00
215.99
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2012 | -10.24K% |
December 31, 2011 | -313.8% |
September 30, 2011 | -765.3% |
June 30, 2011 | -923.3% |
March 31, 2011 | -997.5% |
December 31, 2010 | -218.6% |
September 30, 2010 | -303.3% |
June 30, 2010 | -270.1% |
March 31, 2010 | -231.4% |
December 31, 2009 | -150.4% |
September 30, 2009 | 90.58% |
June 30, 2009 | -182.7% |
March 31, 2009 | -521.0% |
December 31, 2008 | -4.08K% |
September 30, 2008 | -2.07K% |
Date | Value |
---|---|
June 30, 2008 | -1.70K% |
March 31, 2008 | -1.32K% |
December 31, 2007 | |
September 30, 2007 | |
June 30, 2007 | |
March 31, 2007 | |
December 31, 2006 | |
September 30, 2006 | |
June 30, 2006 | |
March 31, 2006 | |
December 31, 2005 | |
September 30, 2005 | |
June 30, 2005 | |
March 31, 2005 | |
March 31, 2004 | -5.06K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Eli Lilly and Co | 25.58% |
Viking Therapeutics Inc | -- |
Akero Therapeutics Inc | -- |
89bio Inc | -- |
Geron Corp | -226.0K% |